Skip to content

Clinical efficacy evaluation and mechanism study of acupuncture on sensitized acupoints for functional dyspepsia

Clinical efficacy evaluation and mechanism study of acupuncture on sensitized acupoints for functional dyspepsia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002249
Enrollment
Unknown
Registered
2025-11-17
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional dyspepsia

Interventions

Western Medicine Group:Oral administration of mosapride citrate tablets
Conventional acupoint groups:Conventional acupuncture
Sensitization acupoint group:Needling at sensitized acupoints/sensitized points

Sponsors

Wuhan First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Subjects who meet all of the following four criteria will be included in the study:1) Meet the Rome IV diagnostic criteria for functional dyspepsia;2) Age: 18-65 years old;3) No acupuncture or related drug treatment has been received in the past three months or there has been acupuncture and drug treatment but the period of drug withdrawal and cleaning has reached three months;4) Be willing to sign the informed consent form and be able and willing to provide follow-up data

Exclusion criteria

Exclusion criteria: Patients who meet any of the following conditions should be excluded.1)Researchers with poor compliance inability to cooperate with research evaluations or inability to participate throughout the entire process;2) Currently taking prokinetic agents anticholinergic drugs and dopamine drugs that may affect gastric motility and currently taking oral anticoagulant and antiplatelet aggregation drugs the drug cleaning period has not reached 3 months;3) Those with a history of gastrointestinal surgery blood system diseases severe cardiovascular and cerebrovascular diseases and other underlying conditions;4) Pregnant or lactating patients and women planning to get pregnant within half a year;5) Allergic reactions to therapeutic drugs and clear contraindications;6) Those with serious mental problems such as depression that interfere with symptom assessment;7) Those who are afraid of needles have a fear of needles or are prone to fainting from needles;8) Those who have received a certain level of cultural education and are capable of independently reading understanding and filling in materials;

Design outcomes

Primary

MeasureTime frame
Overall symptom score evaluation;

Secondary

MeasureTime frame
Serum acetylcholine;functional digestive disorders quality of life FDDQL;gastrin;Self-rating anxiety scale;adverse drug reaction;motilin;The changes in the pain threshold of acupoints;Self-rating depressive scale;Perceived Stress Scale PSS-10;Electrogastrogram;Adverse reactions of acupuncture;

Countries

China

Contacts

Public ContactZhang hongxing

JIANGHAN UNIVERSITY

zhxzhenjiu@163.com13098894887

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026